Europe is a key part of equity allocations. We highlight the case for active management and argue it’s a focus on fundamentals that matters.
European equities continue to attract investor attention. While optimism at the start of the year has given way to greater caution amid heightened volatility and geopolitical uncertainty – most notably rising energy prices – investors continue to engage with the region as an important component of diversified equity portfolios.
The question for professional investors is no longer whether to allocate to Europe, but how to do so. In a market characterised by dispersion, structural change and shifting macroeconomic headwinds, we believe a consistently applied active approach is better suited than broad passive exposure.
Active matters in Europe – especially now
Europe is not a single, homogenous market. It spans multiple countries, currencies, regulatory regimes and sector compositions, resulting in significantly wider valuation and earnings dispersion than in more concentrated markets such as the US. That diversity creates opportunity, but it also demands selectivity.
Several structural dynamics further underline the case for active stock selection:
- AI winners and losers
Sentiment around artificial intelligence is increasingly differentiating companies within the European technology ecosystem. While certain firms benefit directly from capital expenditure and adoption, others face disruption to established business models. Passive exposure risks blurring these distinctions.
- Emerging quality through investment cycles
Fiscal expansion targeting defence, infrastructure and energy transition is creating opportunities in areas with high barriers to entry, engineering complexity and tangible asset backing. Companies operating Europe’s grids, transport networks and industrial supply chains may benefit – but not uniformly.
- Structural change in European banks
After years of post‑crisis constraints, sections of the European banking sector are operating with stronger balance sheets, improving returns on capital and more rational competitive dynamics. Differentiating between beneficiaries and laggards remains critical.
At the same time, other areas face growing challenges. Patent expiries, pricing pressure, rising input costs and evolving consumer dynamics are creating headwinds across parts of pharmaceuticals and consumer staples. Europe today is a market of winners and losers, not one‑way beta exposure.
Ignore the noise, stay anchored to fundamentals
Recent geopolitical events have once again underscored how quickly macro narratives can shift. Elevated energy prices threaten growth expectations and have softened what was previously a more constructive outlook for Europe. History suggests, however, that abandoning long‑term convictions during periods of stress can be damaging to outcomes.
This places a premium on investment processes designed to remain anchored in fundamentals rather than headlines.
The approach underpinning the CT QR Series European Equity Active ETF combines a systematic, data‑driven framework with fundamental insight. Companies are assessed across Quality, Value and Catalyst characteristics, with weightings tailored by industry to reflect genuine drivers of returns. Stocks are ranked within peer groups, ensuring portfolios are built from high‑conviction ideas rather than benchmark constituents.
How fundamentals are applied in practice
Fundamental insight is embedded into the investment process to identify when a company’s underlying prospects are changing – even if market sentiment remains supportive.
A recent example was EssilorLuxottica. Despite strong market enthusiasm around its involvement in AI‑enabled smart glasses, our assessment began to deteriorate as indicators across quality, valuation and earnings momentum weakened. While short‑term narratives continued to influence share‑price volatility, the fundamentals pointed to a less attractive risk‑reward profile, prompting a firmer negative view within the framework.
This illustrates a core advantage of active management: the ability to look through hype, distinguish signal from noise and respond consistently when the underlying investment case weakens.
Crucially, applying this discipline systematically across a broad universe allows for early identification of risk. Since inception in November 2025, the strategy has exited nine individual holdings where fundamentals deteriorated, reinforcing portfolio discipline without materially altering overall market exposure.
Why passive exposure may fall short
Capital‑weighted indices have unintended biases. They allocate the most capital to the largest companies, irrespective of whether fundamentals are improving or weakening. In a market as diverse and structurally complex as Europe, this can increase exposure to legacy business models or rising concentration risks – precisely when selectivity matters most.
An active approach offers greater control – not by attempting to time markets, but by continuously reassessing fundamentals, reallocating capital towards higher‑quality opportunities and avoiding areas where risks are rising.
The bottom line
Despite near‑term uncertainty, Europe remains a strategically important equity allocation. Structural investment themes, wide dispersion and evolving industry dynamics continue to create compelling opportunities for patient capital.
Navigating such a complex landscape calls for more than broad market exposure. A disciplined active approach – grounded in systematic analysis and fundamental insight – can help investors stay invested, manage risk and focus portfolios on the companies best positioned to deliver durable long‑term returns.
